99% Raw Material Brinzolamide Powder CAS 138890-62-7 with Safe Delivery
Product Description
Brinzolamide was introduced as Azopt in the US for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or openangle glaucoma. Brinzolamide is a potent inhibitor of human carbonic anhydrase II lowering IOP after topical administration. It is the second of this class after dorzolamide (1995). Brinzolamide can be prepared in an eight-step sequence from 3-acetyl-2,5-dichlorothiophene. In patients with primary open-angle glaucoma or ocular hypertension, brinzolamide produced significant reductions in IOP and showed less ocular discomfort than dorzolamide.
| Product Name: | Brinzolamide |
| Appearance: | White crystal powder |
| M.F.: | C12H21N3O5S3 |
| Assay: | 99% |
| Grade: | Medicine Grade |
| Certificate: | ISO 9001 |
| Shelf life: | 2 years |
| CAS No: | 138890-62-7 |
